Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma

This study has been terminated.

( Funding has become unavailable )

Study NCT01204450 Information provided by UNC Lineberger Comprehensive Cancer Center

First Received on September 16, 2010. Last Updated on February 10, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Neuroblastoma
Sarcoma

Additional conditions recognized in this trial

Central Nervous System Neoplasms
Nervous System Neoplasms

More general conditions related to this trial

Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Nervous System Diseases
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral

Interventions listed in this trial

temsirolimus
valproic acid (VPA)

Additional drug interventions recognized in this trial

Everolimus
Sirolimus
Valproic Acid

Sponsors listed in this trial

UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)

Back to top of Main Content